Alterations of heart function and Na+-K+-ATPase activity by etomoxir in diabetic rats

Journal of Applied Physiology

Volumn 86, Issue 3, 1999, Pages 812-818

  Kato, Kiminori ^b   Chapman, Donald C ^b   Rupp, Heinz ^b   Lukas, Anton ^b   Dhalla, Naranjan S ^a  

^a ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

^b NONE

Author keywords

Carnitine palmitoyltransferase I; Diabetic heart; Etomoxir; Heart dysfunction in diabetes; Sarcolemmal sodium potassium 3',5' adenosine triphosphatase

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CARNITINE PALMITOYLTRANSFERASE; ETOMOXIR; GLUCOSE; INSULIN; LIOTHYRONINE; STREPTOZOCIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCOSE UTILIZATION; HEART FUNCTION; HEART MUSCLE METABOLISM; HEART VENTRICLE ENDDIASTOLIC PRESSURE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0033056014     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1999.86.3.812     Document Type: Article

References (28)

1. 2+-transport. J. Biol. Chem. 254: 12404-12410, 1979.
2. Argius, L., and K. G. Alberti. Regulation of flux through pyruvate dehydrogenase and pyruvate carboxylase in rat hepatocyte. Effect of fatty acids and glucagon. Eur. J. Biochem. 152: 699-707, 1985.
3. Bricknell, O. L., P. S. Daries, and L. H. Opie. A relationship between adenosine triphosphate, glycolysis and ischemic contracture in the isolated rat heart. J. Mol. Cell. Cardiol. 13: 941-945, 1981.
4. Charlemagne, D., J. Orlowski, P. Oliviero, F. Rannou, C. Sainte Beuve, B. Swynghedauw, and L. K. Lane. Alteration of Na,K-ATPase subunit mRNA and protein levels in hypertrophied rat heart. J. Biol. Chem. 269: 1541-1547, 1994.
5. Dhalla, N. S., V. Elimban, and H. Rupp. Paradoxical role of lipid metabolism in heart function and dysfunction. Mol. Cell. Biochem. 116: 3-9, 1992.
6. Dhalla, N. S., F. Kolar, K. R. Shah, and R. Ferrari. Effects of some L-carnitine derivatives on heart membrane ATPase. Cardiovasc. Drugs Ther. 5, Suppl. 1: 25-30, 1991.
7. Dhalla, N. S., G. N. Pierce, I. R. Innes, and R. E. Beamish. Pathogenesis of cardiac dysfunction in diabetes mellitus. Can. J. Cardiol. 1: 263-281, 1985.
8. +-ATPase activity in congestive heart failure due to myocardial infarction. Am. J. Physiol. 262 (Cell Physiol. 31): C664-C671, 1992.
9. Doyle, D. D., T. J. Kamp, H. C. Palfrey, R. J. Miller, and E. Page. Separation of cardiac plasmalemma into cell surface and T-tubular components. Distribution of saxitoxin- and nitrendipine-binding sites. J. Biol. Chem. 261: 6556-6563, 1986.
10. Eistetter, K., and H. P. O. Wolf. Etomoxir. Drugs Future 11: 1034-1036, 1986.
11. Gick, G. G., M. A. Hatala, D. Chon, and F. Ismail-Beigi. Na,K-ATPase in several tissues of the rat: tissue-specific expression of subunit mRNAs and enzyme activity. J. Membr. Biol. 131: 229-236, 1993.
12. Ku, D. D., and B. M. Sellers. Effect of streptozotocin diabetes and insulin treatment on myocardial sodium pump and contractility of the rat heart. J. Pharmacol. Exp. Ther. 222: 395-400, 1982.
13. Lopaschuk, G. D., S. R. Wall, P. M. Olley, and N. J. Davies. Etomoxir, a carnitine palmitoyltransferase I inhibitor, protects hearts from fatty acid-induced ischemic injury independent of changes in long chain acylcarnitine. Circ. Res. 63: 1036-1043, 1988.
14. McPherson, G. Analysis of radioligand binding experiments. A collection of computer programs for the IBM-PC. J. Pharmacol. Methods 14: 213-228, 1985.
15. Mercer, J. R., and P. B. Dunham. Membrane-bound ATP fuels the Na/K pump. J. Gen. Physiol. 78: 547-568, 1981.
16. +-ATPase isoforms in heart, skeletal muscle, and kidney of diabetic rats. Am. J. Physiol. 265 (Endocrinol. Metab. 28): E243-E251, 1993.
17. Onji, T., and M. Liu. Effect of alloxan-diabetes on the sodium-potassium adenosine triphosphatase enzyme system in dog hearts. Biochem. Biophys. Res. Commun. 96: 799-804, 1980.
18. +-ATPase activity in diabetic rat heart. Am. J. Physiol. 245 (Cell Physiol. 14): C241-C247, 1983.
19. Pitts, B. J. R. Stoichiometry of sodium-calcium exchange in cardiac sarcolemmal vesicles. J. Biol. Chem. 254: 6232-6235, 1979.
20. Rodrigues, B., R. K. Goyal, and J. H. McNeill. Effects of hydralazine on streptozotocin-induced diabetic rats: prevention of hyperlipidemia and improvement in cardiac function. J. Pharmacol. Exp. Ther. 237: 292-299, 1986.
21. Rösen, P., F. J. Schmitz, and H. Reinauer. Improvement of myocardial function and metabolism in diabetic rats by the carnitine palmitoyltransferase inhibitor etomoxir. In: Cardiovascular Disease in Diabetes, edited by M. Nagano, S. Mochizuki, and N. S. Dhalla. Boston, MA: Kluwer Academic, 1992, p. 361-372.
22. Rupp, H., V. Elimban, and N. S. Dhalla. Modification of subcellular organelles in pressure overloaded heart by etomoxir, a carnitine palmitoyltransferase I inhibitor. FASEB J. 6: 2349-2353, 1992.
23. +-pump ATPase of the diabetic rat heart by lipid-lowering interventions. Mol. Cell. Biochem. 132: 69-80, 1994.
24. +-ATPase alpha-subunit isoforms in rat tissues during hypertension. Eur. J. Pharmacol. 292: 163-171, 1995.
25. Schmitz, F. J., P. Rösen, and H. Reinauer. Improvement of myocardial function and metabolism in diabetic rats by the carnitine palmitoyl transferase inhibitor etomoxir. Horm. Metab. Res. 27: 515-522, 1995.
26. +-ATPase. Biochim. Biophys. Acta 988: 185-220, 1989.
27. Vaartjes, W. J., C. G. M. De Haas, and H. P. Haagsman. Effect of sodium 2-[5-(4-chlorophenyl)pentyl]-oxirane-2-carboxylate (POCA) on intermediary metabolism in isolated rat-liver cells. Biochem. Pharmacol. 35: 4267-4272, 1986.
28. Wolf, H. P. O. Aryl-substituted 2-oxirane carboxylic acids: a new group of antidiabetic drugs. In: New Antidiabetic Drugs, edited by C. J. Bailey and P. R. Flatt. London: Smith-Gordon, 1990, p. 699-707.